-
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma
Janssen, J. B. E., Brahm, C. G., Driessen, C. M. L., Nuver, J., Labots, M., Kouwenhoven, M. C. M., Sanchez Aliaga, E., Enting, R. H., de Groot, J. C., Walenkamp, A. M. E., van Linde, M. E. & Verheul, H. M. W., 2024, In: Brain Communications. 6, 4, p. fcae241 fcae241.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
